Last reviewed · How we verify

Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities (PINBOT)

NCT05623111 PHASE2 RECRUITING

The goal of this clinical trial is to test perineural injections (injections around a nerve) of incobotulinumtoxin-A in participants with diabetic nerve pain of the feet and lower legs. The main questions it aims to answer are: * Is the treatment safe and effective? * Does the treatment affect participants quality of life, depression, physical activity, daily life, and sensation? Participants will be treated every 12 weeks, for a total of 24 weeks, with either incobotulinumtoxin-A or a placebo.

Details

Lead sponsorRigshospitalet, Denmark
PhasePHASE2
StatusRECRUITING
Enrolment80
Start dateTue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
CompletionWed Dec 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Interventions

Countries

Denmark